Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such ...

A benchtop bioreactor system developed at Hannover Medical School can produce up to 40 million human immune cells per week ...

DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...

MHH researchers are developing bioreactors to produce millions of human immune cells. The method opens up new opportunities for research and treatment. Researchers at Hannover Medical School (MHH) ...

The university plays a vital role in addressing social challenges and improving quality of life. Its success is built on five dynamic institutes specializing in chemistry and biotechnology, food and ...

To test their setup, researchers allowed algae cells to stick to the surface of the photobioreactor. When they applied a voltage, the bubbles separated the cells from the surfaces without harming them ...

TheraNym Biologics expands its partnership with MSD by investing $150-$175 million in a new mammalian drug manufacturing facility.

Recent advances in cell culture technology have transformed the landscape of viral vaccine production, offering enhanced scalability, efficiency and adaptability compared to traditional egg‐based or ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...